+ 1-971-202-1575 , TollFree:+ 1-800-910-6452
  [email protected]
Male Hypogonadism Market by Therapy (Testosterone Replacement therapy and Gonadotropin and Gonadotropin-Releasing Hormones Therapy (Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), and Gonadotropin-Releasing Hormone (GnRH))), Drug Delivery (Topical Gels, Injectables, Transdermal Patches, and Others), and Type (Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022
  • Published : January , 2017
  • |
  • Number of Pages : 157
  • |
  • Published By : Allied Market Research



Report Overview
Male hypogonadism is a medical condition characterized by the inability of the testes to produce sufficient amount of testosterone, which is responsible for the development of secondary sexual characteristics. This results in underdevelopment of muscles, impaired growth of body hair, development of breast tissues, and lack of deepening of the voice.




Similar Market Studies

PUBLISHED REPORTS


UPCOMING REPORTS


Reports and Intelligence


We Accept

  • Stay Connected

Copyright ©2018 Reportsandintelligence All Rights Reserved